Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.10.27.762131

Fixing the Measurement Model Before the Selection Heuristics: Optimiser Repairs for Living-Cell Self-Driving Laboratories

Abstract

Closed-loop Bayesian optimisation assumes things that living cells do not provide. A measured cell is used up and cannot be measured again, cultures drift over a campaign, day-to-day batch offsets shift every reading, and cell-to-cell variation is heavy-tailed and mixed with probe failures. When an autonomous loop goes wrong under these conditions, the usual response is a selection-level repair: change the incumbent, replicate the current best, or explore more. The other option is to change what the model assumes about each measurement. We compared the two in a simulated living-cell laboratory with common random numbers, crossing two surrogate models with four selection repairs over three response surfaces, four pathology regimes and 60 seeds (8,820 campaigns of 30 rounds, five destroyed cells per round). A measurement-aware model, using a robust per-condition summary, shrunk per-condition noise and additive drift and day terms, lowered final simple regret against plain GP-EI by 0.042 [0.024, 0.061] under heavy tails and by 0.039 [0.013, 0.064] with all pathologies on, and raised 90% band coverage under drift from 0.83 to 0.95. It cost 0.015 [0.004, 0.027] on clean data. None of the selectionlevel repairs we tested helped either model once the data were contaminated, and using the best posterior mean as the incumbent raised regret in every regime for both models (+0.015 to +0.045). Because that variant is not integrated noisy expected improvement (NEI), we extended the study with an independent reimplementation of the simulator (10,260 further campaigns plus 4,320 for trajectory and sensitivity analyses). It reproduced the direction of the main effects with smaller magnitudes, showed that the measurement-aware gain persisted when drift was halved or doubled and when the probe-failure rate ranged from 5% to 20%, and found that integrated NEI did not hurt and gave the lowest regret when paired with the measurement-aware model. It also showed that offset-removed coverage overstates absolute calibration under drift. Within simulation, the measurement model is the first place to intervene; we have not tested real cell data.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Brimo, N., Serdaroglu, D. C.. 2026-10-28. Fixing the Measurement Model Before the Selection Heuristics: Optimiser Repairs for Living-Cell Self-Driving Laboratories. https://doi.org/10.64898/2026.10.27.762131

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Carrier-Limited Release Risk in Electrospun Nanofibers for Regenerative Endodontics: Constraint Discovery from 25 Formulations

Regenerative endodontics needs an intracanal carrier that keeps disinfecting across a dressing interval that clinicians schedule at one to four weeks, without harming the stem cells that rebuild the pulp. We ask what one completed 25-formulation electrospinning campaign of poly(vinylpyrrolidone) (PVP) fibers carrying metronidazole, ciprofloxacin, minocycline and Ca(OH)2 can decide, and use machine learning for constraint discovery and decision support rather than as a new predictor. After an audit against the source thesis, logistic regression predicts fine-fiber formation at 96% leave-one-out accuracy, but a one-threshold rule does as well, the gain over the 80% majority baseline is not significant (exact McNemar p = 0.125), and accuracy falls to 84% when mixture loading is encoded per component. Diameter models interpolate within formulation families (ridge MAE 193 nm, 95% CI 96 to 317 nm) and fail across them (R^2 < 0). Because the campaign never measured release, we assemble a same-drug, cross-carrier evidence table: 17 bounded metronidazole and ciprofloxacin observations from seven studies, with two-sided censoring. Water-soluble carriers (PVP, PVA) completed release within 80 h (PVP within 8 h); no water-insoluble monolithic carrier reached 90% within its observation window, releasing 1.5 to 50%; both within-study comparisons separate at matched loading; and blend, core-shell and thick-mat architectures released over 3 to 28 days. The PVP mats therefore carry a carrier-limited release risk, not a proven ceiling, and one dissolution experiment can confirm or overturn it. A censoring-aware screen keeps three necessarily and one possibly nondominated formulation, and fixed-budget replays show that uncertainty sampling finds failed formulations sooner, except the one it is confidently wrong about.

bioinformatics↗

CellMethMarker provides an integrated database of human cell- and tissue-type-specific DNA methylation markers

Cell- and tissue-type-specific DNA methylation markers provide epigenetic signatures of cellular identity and are widely used to infer cellular origin from bulk and single-cell methylomes. Existing resources mainly emphasize disease-associated biomarkers, methylome atlases, genomic annotations or RNA-based cell markers, leaving an unmet need for an integrated region-level resource dedicated to such markers. Here we present CellMethMarker (http://gu-zhanglab.hfcas.ac.cn/CellMethMarker), a curated database integrating 347,514 de novo markers derived from uniformly processed whole-genome and reduced-representation bisulfite sequencing datasets, 2,203,507 literature-derived marker records and harmonized metadata for 2,810 samples. CellMethMarker enables cell- and tissue-centered marker retrieval, coordinate-based search, genome-browser visualization, interactive methylation analysis and data download. In an independent single-cell methylome atlas, these markers recover the expected cell-type-associated methylation patterns, and a platform-matched reference built from them lowers the mean deconvolution error from 0.365 to 0.144. CellMethMarker therefore links region-level DNA methylation variation to cellular identity and supports methylome-based cell-type annotation and deconvolution.

bioinformatics↗

IG-28 enables identification and quantification of high-confidence isoforms from large bulk and single-cell full-length cDNA datasets

The technology to sequence full-length transcriptomes from bulk and single-cell samples has rapidly advanced. As a result, full-length cDNA datasets now reach billions of reads in size which is beyond the capability of most established isoform identification tools. Here, we introduce IG-28 which addresses this challenge with its capability to process and analyze large fl-cDNA datasets fast and using minimal computational resources. In contrast to its predecessor Mandalorion, IG-28 is not limited to bulk fl-cDNA but is capable of parsing, processing, and analyzing single-cell fl-cDNA datasets. It does so in a lightweight, flexible manner, integrating seamlessly with established scRNA-seq analysis workflows. We benchmarked IG-28 against a variety of established and new isoform identification tools using several bulk and a complex single-cell fl-cDNA dataset and found that IG-28 consistently outperformed the other tools by identifying high-confidence public isoforms.

bioinformatics↗